Effect of Packaging Material on Color Properties of Catsup Tomato Sauce

Catsup and tomato sauce products currently are one of the most popular and commercially available table sauces particularly consumed by young people and families around the world in recent decades. In this study colorimetric properties of catsup sauce samples including L*, a* and b* values in different packaging materials including PP, PE, PET, Glass and Sachet have been investigated during and after 180 days storage time at 22̊ C (environmental temperature). Hunter Lab system has been used to evaluate the color values of sauce samples. According to obtained results of experimental measurements and sensory evaluations, PP and PE packaging materials affected significantly color properties of catsup sauce samples during and after the storage time that it because of interaction between packaging material and lycopene components in catsup sauce samples. Finally, According to consumer prefers to darker tomato and catsup sauce products, PP and PE are not suitable for packaging of catsup sauce production

Comparison of the Effect Of 0.2% Chlorhexidine and Xylitol Plus 920 Ppm Fluoride Mouthwashes on Count of Salivary Streptococcus Mutants, a Pilot Study

Statement of the Problem: Dental caries is a common chronic disease. Mouthwashes and other preventive approaches play an important role in caries prevention. Finding the most efficient mouthwash in the market is always a concern for dentists and patients. Purpose: This study aimed to assess the effect of chlorhexidine (Behsa, Iran) and xylitol plus 920 ppm fluoride (FX) (Fuchs, Germany) mouthwash on salivary Streptococcus mutans (S. mutans), which is the main microorganism responsible for dental caries. Materials and Method: This single-blind randomized clinical trial was conducted on 30 dental students, divided into two groups. The salivary count of S. mutans was measured at the beginning of the study. Group 1 students used chlorhexidine mouthwash while group 2 used FX mouthwash for two weeks. Saliva samples were collected again and salivary count of S. mutans was determined. Data were analyzed using Mann Whitney and Wilcoxon signed rank tests Results: Salivary count of S.mutans significantly decreased in the two groups after using the mouthwashes (p 0.05). Conclusion: Within the limitations of this study, the results showed that both mouthwashes could decrease S. mutans count

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Genomic recombination of infectious laryngotracheitis virus (ILTV) vaccines

© 2020 Omid FakhriInfectious laryngotracheitis virus (ILTV) is an alphaherpesvirus that causes acute respiratory disease in chickens. This disease causes economic loss in poultry industries worldwide and is a major concern for animal health and welfare. Although, ILTV vaccines are in use to control disease, biosecurity breaches and continuous evolution of the ILTV genome make outbreak prevention difficult. Genomic recombination plays a role in diversification of herpesvirus genomes and has been suggested to be an important alternative evolutionary mechanism in herpesviruses such as ILTV. In previous studies of ILTV, two new genotypes of virulent field strains were shown to be independent recombinants derived from distinct attenuated commercial ILTV vaccines. These new strains became the dominant field viruses responsible for widespread and severe disease outbreaks in Australian poultry flocks. This project aimed to determine the frequency of these recombination events and the conditions that can facilitate recombination using in vitro, in ovo and in vivo studies. In these series of studies, a high-throughput and cost-effective method for detection of recombinant ILTVs was developed and was used to analyse the viruses generated under multiple infection conditions. The results from these analyses indicated that genomic recombination between vaccine strains of ILTV is a frequent event and takes place under a broad range of conditions. De novo mutation was detected in addition to genomic recombination. The capacity of ILTV vaccines to allow secondary infection by another ILTV vaccine (i.e. superinfection) was investigated at both cellular and natural host levels. The result of this investigation showed that superinfection can occur after administration of ILTV vaccines, providing the virus with ample opportunity for genomic recombination. The outcomes of these studies include advances in fundamental understanding about the factors that lead to ILTV recombination

Development and application of high?resolution melting analysisfor the classification of infectious laryngotracheitis virus strainsand detection of recombinant progeny

AbstractLive attenuated vaccines against infectious laryngotracheitis virus (ILTV) are widely used in the poultry industry to controldisease and help prevent economic losses. Molecular epidemiological studies of currently circulating strains of ILTV withinpoultry flocks in Australia have demonstrated the presence of highly virulent viruses generated by genomic recombinationevents between vaccine strains. In this study, high-resolution melting (HRM) analysis was used to develop a tool to classifyILTV isolates and to investigate ILTV recombination. The assay was applied to plaque-purified progeny viruses generatedafter co-infection of chicken embryo kidney (CEK) monolayers with the A20 and Serva ILT vaccine strains and also toviruses isolated from field samples. The results showed that the HRM analysis is a suitable tool for the classification ofILTV isolates and can be used to detect recombination between ILTV vaccine strains in vitro. This method can be used toclassify a broad range of ILTV strains to facilitate the classification and genotyping of ILTV and help to further understandrecombination in these viruses

Physicochemical and Bacterial Properties of Pasteurized Milk Samples Collected from Tabriz, Northwestern Iran

Milk and dairy products are important components of a balanced diet. Milk does have distinct physicochemical, biological and microbial characteristics. The bacterial contamination of milk not only reduces the nutritional quality but its consumption threatens health of the society. In this study, 100 pasteurized milk samples were collected randomly from Tabriz City, northwestern and were analyzed for total plate count (TPC), coliform, E. coli and some physicochemical properties (pH, titratable acidity and density). 33.3% of samples had unacceptable microbial contamination in both warm and cold seasons. E. coli contamination was not detected in all milk samples, but 54% of pasteurized milk samples were contaminated with coliforms. The pH value (6.6-6.8) and titratable acidity (0.14-0.16%) were in acceptable range. The means value of samples’ density was 1028.79±1.04. Lower microbial contamination level in this area indicates that the dairy factories are concerned about appropriate sanitary practice and pasteurization process

Inhibitory Effect of Mentha Longifolia L. Essential Oil against Listeria Monocytogenes Using Transmission Electron Microscopy

Inevitable side effects of chemical food preservatives and drug resistance have increased interests on use of natural preservatives derived from plants. Therefore, in the present paper, the biological properties of Mentha longifolia L. essential oil were studied. Chemical analysis (GC/MS) and antibacterial properties of the Mentha longifolia L. essential oil (EO) was under different temperature and pH values were evaluated with special reference to the mechanism of inhibition Listeria monocytogenes growth at ultra-structural level by TEM.Minimum inhibition concentration and minimum bactericidal concentration values of the M. longifoli L. EO showed to be in the range of 150-9600 μg/ml. These MIC, MBC results and cell membrane damage observed in TEM evaluation indicate that this EO has a high potential of anti-Listeria effect.It is concluded that M. longifoli L. EO could be effectively used as a natural biopreservative against foodborne bacteria.</p

A survey on anticancer effects of artemisinin, iron, miconazole, and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer) cell lines

Context: Anticancer properties of artemisinin and its derivatives have been shown in many experiments. Aims: Addition of butyric acid, miconazole, and iron to this traditional drug has been done in order to enhance its anticancer potency. Materials and Methods: Cell lines 5637 and 4T1, were cultivated and classified into 13 groups of three each. Different doses of artemisinin with constant doses of iron, miconazole and butyric acid, were added to the cultures. At the end of exposure pathological and enzymatic studies were performed. Results: In four groups treated with different doses of artemisinin and iron, dose-dependent changes were observed. These changes included apoptosis and necrosis with dominance of apoptosis. The supernatant lactate dehydrogenase (LDH) level was increased in a dose-dependent manner, but there was no significant increase in the cell fraction of malonyldialdehyde (MDA) or LDH. In four other groups, which received miconazole, butyric acid and iron in addition to different doses of artemisinin, necrosis was more prominent than apoptosis, and the MDA level did not show any significant change, but LDH was increased. The groups treated with miconazole showed identical changes, with less severity compared to combination therapy groups. In butyric acid-treated groups, the only detectable changes were, mild cell swelling, few apoptosis, and rare necrosis. Conclusions: A combination therapy with artemisinin can be more effective against cancer cells than monotherapy with that. Butyric acid was not effective on cancer cells. Miconazole deviated the nature of cell death from apoptosis to necrosis and it must be used under caution

Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.

Infectious laryngotracheitis (ILT) is a respiratory disease that affects chickens. It is caused by the alphaherpesvirus, infectious laryngotracheitis virus (ILTV). This virus undergoes lytic replication in the epithelial cells of the trachea and upper respiratory tract (URT) and establishes latent infection in the trigeminal ganglia (TG) and trachea. Live attenuated vaccines are widely used to control ILT. At least one of these vaccines can establish latent infections in chickens, but this has not been demonstrated for all vaccines. The aim of the current study was to determine the capacity of three commercially available vaccines (SA2, A20 and Serva) and a glycoprotein G deletion mutant vaccine candidate (ΔgG ILTV) to establish latent infection in the TG of specific pathogen free (SPF) chickens. Five groups of 7-day-old SPF chickens were eye-drop vaccinated with either one of the vaccine strains or mock-vaccinated with sterile media and followed until 20 or 21 days post-vaccination (dpv). ILTV DNA was detected at 20-21 dpv in the TG of 23/40 (57.5%) vaccinated SPF chickens (SA2 = 10/10; A20 = 6/10; Serva = 3/10; ΔgG = 4/10) by PCR, but virus could not be reactivated from TG co-cultivated with primary chicken embryo kidney cells. In the birds from which ILTV DNA was detected in the TG, ILTV DNA could not be detected in the URT or trachea of 3 birds in each of the SA2, A20 and Serva vaccinated groups, and in 4 birds in the ΔgG vaccinated group, indicating that these birds were latently infected in the absence of active lytic replication and virus shedding. Results from this study demonstrate the capacity of commercial ILTV vaccines to establish latent infections and underline their importance in the epidemiology of this disease

Hepatobiliary organoids derived from leporids support the replication of hepatotropic lagoviruses

The genus Lagovirus of the family Caliciviridae contains some of the most virulent vertebrate viruses known. Lagoviruses infect leporids, such as rabbits, hares and cottontails. Highly pathogenic viruses such as Rabbit haemorrhagic disease virus 1 (RHDV1) cause a fulminant hepatitis that typically leads to disseminated intravascular coagulation within 24-72 h of infection, killing over 95 % of susceptible animals. Research into the pathophysiological mechanisms that are responsible for this extreme phenotype has been hampered by the lack of a reliable culture system. Here, we report on a new ex vivo model for the cultivation of lagoviruses in cells derived from the European rabbit (Oryctolagus cuniculus) and European brown hare (Lepus europaeus). We show that three different lagoviruses, RHDV1, RHDV2 and RHDVa-K5, replicate in monolayer cultures derived from rabbit hepatobiliary organoids, but not in monolayer cultures derived from cat (Felis catus) or mouse (Mus musculus) organoids. Virus multiplication was demonstrated by (i) an increase in viral RNA levels, (ii) the accumulation of dsRNA viral replication intermediates and (iii) the expression of viral structural and non-structural proteins. The establishment of an organoid culture system for lagoviruses will facilitate studies with considerable implications for the conservation of endangered leporid species in Europe and North America, and the biocontrol of overabundant rabbit populations in Australia and New Zealand